M. Polée

2.1k total citations
13 papers, 330 citations indexed

About

M. Polée is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, M. Polée has authored 13 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Oncology. Recurrent topics in M. Polée's work include Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Esophageal and GI Pathology (3 papers). M. Polée is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Esophageal and GI Pathology (3 papers). M. Polée collaborates with scholars based in Netherlands, United States and Norway. M. Polée's co-authors include Ate van der Gaast, G. Stoter, Peter D. Siersema, Ted A.W. Splinter, M.E.L. van der Burg, Ferry A.L.M. Eskens, T.C. Kok, H.W. Tilanus, Jaap Verweij and Wim C.J. Hop and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M. Polée

13 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Polée Netherlands 8 216 192 115 32 23 13 330
Antonio Manganelli Italy 12 176 0.8× 147 0.8× 96 0.8× 42 1.3× 38 1.7× 16 329
Kyriakos Zafirellis Greece 9 170 0.8× 219 1.1× 70 0.6× 27 0.8× 44 1.9× 9 328
Yoichi Saitoh Japan 9 82 0.4× 202 1.1× 156 1.4× 37 1.2× 34 1.5× 14 334
Tzer‐Zen Hwang Taiwan 10 95 0.4× 208 1.1× 135 1.2× 48 1.5× 43 1.9× 29 392
Ewa Pomianowska Norway 12 82 0.4× 214 1.1× 318 2.8× 28 0.9× 38 1.7× 14 395
Sen‐Ei Shai Taiwan 12 142 0.7× 125 0.7× 64 0.6× 22 0.7× 48 2.1× 30 307
Cian Muldoon Ireland 9 222 1.0× 246 1.3× 89 0.8× 54 1.7× 77 3.3× 31 411
Lan Mu China 11 96 0.4× 139 0.7× 153 1.3× 66 2.1× 78 3.4× 33 362
Cristina Iosif Romania 9 81 0.4× 81 0.4× 99 0.9× 45 1.4× 66 2.9× 34 275
Shun Ishiyama Japan 10 102 0.5× 138 0.7× 100 0.9× 18 0.6× 46 2.0× 98 322

Countries citing papers authored by M. Polée

Since Specialization
Citations

This map shows the geographic impact of M. Polée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Polée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Polée more than expected).

Fields of papers citing papers by M. Polée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Polée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Polée. The network helps show where M. Polée may publish in the future.

Co-authorship network of co-authors of M. Polée

This figure shows the co-authorship network connecting the top 25 collaborators of M. Polée. A scholar is included among the top collaborators of M. Polée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Polée. M. Polée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kwakman, Johannes J.M., Lieke H. J. Simkens, Johan M. van Rooijen, et al.. (2017). Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group. Annals of Oncology. 28(6). 1288–1293. 47 indexed citations
2.
Kwakman, Johannes J.M., Lieke H. J. Simkens, Johan M. van Rooijen, et al.. (2017). Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group. European Journal of Cancer. 72. S5–S5. 1 indexed citations
3.
Meulenbeld, Hielke J., Erik van Werkhoven, J.L. Coenen, et al.. (2012). Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). European Journal of Cancer. 48(16). 2993–3000. 31 indexed citations
4.
5.
Meulenbeld, Hielke J., Erik van Werkhoven, J.L. Coenen, et al.. (2011). Randomized phase III study of docetaxel with or without risedronate in patients with bone metastases from castration-resistant prostate cancer (CRPC): The Netherlands Prostate Study (NePro).. Journal of Clinical Oncology. 29(15_suppl). 4518–4518. 3 indexed citations
6.
Reyners, Anna K.L., Willem M. Smit, Michael Schaapveld, et al.. (2009). Adding the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin in first line for stage IC-IV epithelial ovarian cancer: A randomized phase II study. Journal of Clinical Oncology. 27(15_suppl). 5545–5545. 1 indexed citations
7.
8.
Polée, M., H.W. Tilanus, F. Eskens, et al.. (2003). Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Annals of Oncology. 14(8). 1253–1257. 14 indexed citations
9.
Polée, M., Wim C.J. Hop, T.C. Kok, et al.. (2003). Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. British Journal of Cancer. 89(11). 2045–2050. 81 indexed citations
10.
Polée, M., Ferry A.L.M. Eskens, M.E.L. van der Burg, et al.. (2002). Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. British Journal of Cancer. 86(5). 669–673. 63 indexed citations
11.
Polée, M., Jaap Verweij, Peter D. Siersema, et al.. (2002). Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer. European Journal of Cancer. 38(11). 1495–1500. 15 indexed citations
12.
13.
Bilo, H. J. G., Rijk O. B. Gans, M. Polée, et al.. (1991). Catecholamines and Blood Glucose Control in Type 1 Diabetes. Diabetic Medicine. 8(S2). S108–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Manganelli Breakdown of academic impact, for papers by Kyriakos Zafirellis Breakdown of academic impact, for papers by Yoichi Saitoh Breakdown of academic impact, for papers by Tzer‐Zen Hwang Breakdown of academic impact, for papers by Ewa Pomianowska Breakdown of academic impact, for papers by Sen‐Ei Shai Breakdown of academic impact, for papers by Cian Muldoon Breakdown of academic impact, for papers by Lan Mu Breakdown of academic impact, for papers by Cristina Iosif Breakdown of academic impact, for papers by Shun Ishiyama
Rankless by CCL
2026